Decoding the lipid etiology of atherogenic index of plasma and gout: establishing the causal role of triglycerides through NHANES, Mendelian randomization, and network pharmacology. [PDF]
Cardiovasc Diabetol Endocrinol RepTian Y, Zhang X, Gao S, Wang H.
europepmc +1 more source
Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio-renal-metabolic risk modulation. [PDF]
Eur Heart J Cardiovasc PharmacotherBorghi C, Fogacci F, Cicero AFG.
europepmc +1 more source
Axial gout diagnosed by dual-energy CT in a young normouricaemic man with recurrent nephrolithiasis: a case-based review. [PDF]
Rheumatol IntXiaoguang C, Xueyi L, Xin Y.
europepmc +1 more source
Increased risk of atrial fibrillation in young adults with gout: a nationwide cohort study. [PDF]
Front Cardiovasc MedKang E, Han KD, Song GG, Jung JH, Lee Y.
europepmc +1 more source
Allopurinol Desensitization: Is There Still a Place in Clinical Practice? [PDF]
Int J Rheum DisLouthrenoo W.
europepmc +1 more source
Annual gout flare frequency as a marker of sustained cardiovascular risk: a clinical threshold for risk stratification. [PDF]
Rheumatology (Oxford)Tung KT, Chen SC, Lee C.
europepmc +1 more source
The Dual Role of Exosomes in Gout: From Inflammatory Amplifiers to Therapeutic Regulators. [PDF]
InflammationGao X, Zhang J, Kong X, Xue Y, Fan W.
europepmc +1 more source
A Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HP501 in Male Chinese Gout Patients with Hyperuricemia. [PDF]
Clin Pharmacol Drug DevChen L +9 more
europepmc +1 more source
A machine learning approach to metabolomics identifies putative biomarker candidates and dysregulated pathways for distinguishing gout from asymptomatic hyperuricemia in the Zhuang population. [PDF]
MetabolomicsWei Y +8 more
europepmc +1 more source
Biomaterial-Based Strategies for Gout Therapy: Recent Advances, Current Challenges, and Future Perspectives - A Review. [PDF]
Int J NanomedicineZhang Z +9 more
europepmc +1 more source